Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,001 to 2,020 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive review about SARS-CoV-2. | Future Virol | 2020 | 33224265 | PubTator, text mining | PubMed |
| Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site. | Nat Commun | 2020 | 33208735 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19. | F1000Res | 2020 | 33204411 | PubTator, text mining | PubMed |
| Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis. | EPMA J | 2020 | 33204369 | PubTator, text mining | PubMed |
| A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins. | Signal Transduct Target Ther | 2020 | 33203855 | PubTator, text mining | PubMed |
| A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening. | ChemRxiv | 2020 | 33200116 | PubTator, text mining | PubMed |
| In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis. | Comput Struct Biotechnol J | 2020 | 33200027 | PubTator, text mining | PubMed |
The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking. | J Funct Foods | 2020 | 33199981 | PubTator, text mining | PubMed |
| COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response. | Front Mol Biosci | 2020 | 33195400 | PubTator, text mining | PubMed |
| Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition. | Front Microbiol | 2020 | 33193115 | PubTator, text mining | PubMed |
| Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA. | Mol Cell | 2020 | 33188728 | PubTator, text mining | PubMed |
| Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics. | Int Immunopharmacol | 2020 | 33182073 | PubTator, text mining | PubMed |
| Tomatidine inhibits porcine epidemic diarrhea virus replication by targeting 3CL protease. | Vet Res | 2020 | 33176871 | PubTator, text mining | PubMed |
| Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy. | Sci Rep | 2020 | 33173052 | PubTator, text mining | PubMed |
| Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations. | PLoS One | 2020 | 33170902 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh. | Gene Rep | 2020 | 33163695 | PubTator, text mining | PubMed |
| Threading the Pieces Together: Integrative Perspective on SARS-CoV-2. | Pathogens | 2020 | 33158051 | PubTator, text mining | PubMed |
| Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach. | Sci Rep | 2020 | 33154404 | PubTator, text mining | PubMed |
| CRISPR/Cas13: A potential therapeutic option of COVID-19. | Biomed Pharmacother | 2020 | 33152914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=101